Q2 Sees Double-Digit Growth, Banking, IT, Pharma Lag Behind
In the September quarter, companies showed strong revenue growth of 22.1% and net profit growth of 27.5%, outperforming the previous quarter. However, banking, IT, and pharmaceutical sectors experienced slower growth. Operating margins improved excluding lending, reflecting better performance in non-banking sectors. Analysts predict 13 of 18 sectors will achieve double-digit sales growth in upcoming quarters.
ET Markets·



